International Biotechnology (LON:IBT – Get Free Report) insider Gillian Elcock bought 1,407 shares of the business’s stock in a transaction that occurred on Wednesday, July 24th. The shares were bought at an average price of GBX 709 ($9.17) per share, with a total value of £9,975.63 ($12,901.75).
International Biotechnology Stock Performance
International Biotechnology stock opened at GBX 708 ($9.16) on Friday. The firm has a market capitalization of £277.11 million, a P/E ratio of 674.29 and a beta of 0.18. The stock has a fifty day moving average price of GBX 656.30 and a two-hundred day moving average price of GBX 651.59. International Biotechnology has a 52-week low of GBX 548 ($7.09) and a 52-week high of GBX 720 ($9.31). The company has a debt-to-equity ratio of 8.19, a current ratio of 0.27 and a quick ratio of 0.32.
International Biotechnology Increases Dividend
The company also recently announced a dividend, which will be paid on Friday, August 23rd. Investors of record on Thursday, July 25th will be given a dividend of GBX 14.50 ($0.19) per share. The ex-dividend date is Thursday, July 25th. This represents a dividend yield of 2.28%. This is a boost from International Biotechnology’s previous dividend of $13.90. International Biotechnology’s dividend payout ratio (DPR) is 2,666.67%.
International Biotechnology Company Profile
International Biotechnology Trust plc specializes in investments in development stage and late stage companies. The majority of the fund's assets are generally invested in smaller and mid-capitalization quoted companies, with a minority in larger capitalization quoted companies. It makes long only investments.
Featured Articles
- Five stocks we like better than International Biotechnology
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- 3M Surprises and Rebound Accelerates: It Isn’t Too Late To Get In
- Buy P&G Now, Before It Sets A New All-Time High
- Skechers Stock Shows Strength Among Consumer Discretionary Sector
- 3 Warren Buffett Stocks to Buy Now
- Tech Stocks Tumble, These Stocks Present Buying Opportunity
Receive News & Ratings for International Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for International Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.